摘要
目的:介绍胰岛素及其类似物的进展和临床应用概况,并评价其疗效与安全性。方法:查阅近期国内外有关文献,进行分析、归纳与评价。结果与结论:大量的循证医学研究证实,胰岛素及其类似物进展迅速,因其可迅速降低餐后血糖,亦被称为“速效胰岛素”或“餐时胰岛素”,保证了糖尿病患者高质量的生活,成为当前首选治疗药物,并在治疗糖尿病及其并发症方面显示了良好的临床和市场前景。
Objective: To summarize the aspect of clinical usage and progress on insulin and insulin similitude, and to evaluate their clinical efficacy and safety. Methods: To review or analyze and evaluate the literatures at home and abroad in recent years. Results and Conclusion: Large numbers of indication-based medical studies have proved that advance in insulin and its similitude has been swiftly in recent years, they can quickly decrease PBS, thus called name of “quick results insulin” and “mealtime insulin”, insulin and its similitude can guarantee life quality of patients with diabetes mellitus, it has become the first choice drug for diabetes mellitus, so it have broad prospects in application and market potential for treatment of diabetes mellitus diseases or complication.
出处
《中国药业》
CAS
2005年第11期21-23,共3页
China Pharmaceuticals
关键词
糖尿病
胰岛素
胰岛素类似物
血糖
进展
diabetes mellitus
insulin
insulin similitude
blood sugar
progress